Bank of America’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bank of America’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-34,500	Closed	-$5.96M	–	7683
2015 Q1	$5.96M	Sell	34,500 -151,500	-81%	-$22.2M	﹤0.01%	2314
2014 Q4	$21.4M	Buy	186,000 +168,300	+951%	+$20.4M	0.01%	1340
2014 Q3	$2.77M	Sell	17,700 -30,300	-63%	-$4.39M	﹤0.01%	3093
2014 Q2	$5.92M	Buy	48,000 +31,200	+186%	+$3.45M	﹤0.01%	2413
2014 Q1	$1.74M	Sell	16,800 -200	-1%	-$20.5K	﹤0.01%	3341
2013 Q4	$1.53M	Buy	17,000 +3,400	+25%	+$271K	﹤0.01%	3601
2013 Q3	$910K	Buy	13,600 +8,600	+172%	+$593K	﹤0.01%	4031
2013 Q2	$331K	Buy	+5,000	New	+$286K	﹤0.01%	5143

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Bank of America's SLXP Position: Q2 2015 in Review

Bank of America sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 358,907 shares — an estimated $62M sold.

Bank of America first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $199M in Q2 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Bank of America reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Bank of America sold 358,907 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $62M.
Bank of America first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Bank of America's SALIX PHARMACEUTICALS LTD DEL position peaked at $199M in Q2 2013.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Bank of America's 13F filing for Q2 2015, filed 14 Aug 2015.